Paul J Collins

Cited by

	All	Since 2019
Citations	370	312
h-index	7	6
i10-index	6	6

2013201420152016201720182019202020212022202320241 1 4 9 8 33 21 41 71 74 71 34

Public access

View all

6 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Bernhard MoserCardiff UniversityVerified email at cardiff.ac.uk
Claire Shannon-LoweThe University of BirminghamVerified email at bham.ac.uk
Carmela De SantoBirmingham UniversityVerified email at bham.ac.uk
Michelle McCullyVerified email at immunocore.com
Daniel LeglerProfessor and Director Biotechnology Institute Thurgau at the University of KonstanzVerified email at bitg.ch
Livingstone FultangCurrent: Roche/Genentech. Previously: University of Birmingham, Newcastle UniversityVerified email at bham.ac.uk
Marcus ThelenInstitute for Research in BiomedicineVerified email at irb.usi.ch
Mariagrazia UguccioniInstitute for Research in BiomedicineVerified email at irb.usi.ch
Hayden PearceUniversity of BirminghamVerified email at bham.ac.uk
Matthias EberlCardiff University, School of MedicineVerified email at cf.ac.uk
Andy ChevigneLuxembourg Institute of HealthVerified email at lih.lu
Max MeyrathDoctor of Biomedical and Pharmaceutical SciencesVerified email at lih.lu

Paul J Collins

Ghent University - Inflammation Research Centre

Verified email at ugent.be

Immunology liver disease myeloid cells macrophages chemokines


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers L Fultang, S Panetti, M Ng, P Collins, S Graef, N Rizkalla, S Booth, ... EBioMedicine 47, 235-246, 2019	135	2019
Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4 PJ Collins, ML McCully, L Martínez-Muñoz, C Santiago, J Wheeldon, ... The FASEB Journal 31 (7), 3084, 2017	79	2017
CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection C Dai, P Basilico, TP Cremona, P Collins, B Moser, C Benarafa, M Wolf The Journal of Immunology 194 (12), 5980-5989, 2015	64	2015
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells PJ Collins, CP Fox, L George, H Pearce, G Ryan, C De Santo, F Mussai, ... Blood, The Journal of the American Society of Hematology 137 (2), 203-215, 2021	31	2021
Skin metabolites define a new paradigm in the localization of skin tropic memory T cells ML McCully, PJ Collins, TR Hughes, CP Thomas, J Billen, VB O’Donnell, ... The Journal of Immunology 195 (1), 96-104, 2015	28	2015
CXCL14 preferentially synergizes with homeostatic chemokine receptor systems A Kouzeli, PJ Collins, M Metzemaekers, M Meyrath, M Szpakowska, ... Frontiers in immunology 11, 561404, 2020	26	2020
Increased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion S Jervis, P Collins, D Tate, L Foster, V Bowman, C Adhern, A Bloor, J Yin, ... International journal of immunogenetics 40 (2), 116-119, 2013	7	2013
PHENOTYPIC IDENTIFICATION OF EBV-INFECTED LYMPHOCYTES FOR THE DIFFERENTIAL DIAGNOSIS OF HLH, CAEBV AND PTLD; A CLINICALLY APPLICABLE, FLOW-CYTOMETRY-BASED PERIPHERAL BLOOD ASSAY N Martinez-Calle, C Shannon-Lowe, P Collins, D Lewis, CP Fox HemaSphere 3 (S1), 925-926, 2019		2019
Characterisation of CXCL14 function and target cells in blood and tissues PJ Collins Cardiff University, 2016		2016

The system can't perform the operation now. Try again later.

Articles 1–9

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors